The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.20 (16.667%)
Open: 1.30
High: 1.30
Low: 1.30
Prev. Close: 1.30
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Physiomics Successfully Completes Innovate UK Grant Project

Mon, 12th Mar 2018 11:34

LONDON (Alliance News) - Physiomics PLC said Monday it has successfully completed the Innovate UK grant cancer treatment project, receiving GBP131,000 in funding over the course of the project.

The UK grant cancer treatment project was originally announced back in January 2017.

In February, the project was signed off by Innovate UK. As a result, in line with expectations, the company received GBP131,000 in funding over the life of the project with GBP81,000 due to be recognised in the current financial year.

For the year to the end of June 2017, Physiomics generated a GBP530,399 loss on revenue - including grant income - of GBP270,465.

"The project "Decision Support System For Stratified Cancer Treatment" analysed data from over 400 oesophageal cancer patients to determine patient and disease specific factors that could help guide treatment to achieve the best outcomes, and created a tool for healthcare professionals to visualise this data," Physiomics said in a statement.

Physiomics - a medical prediction software firm - intends to publish the results over the course of 2018 and is actively seeking additional grants in this space.

Shares in Physiomics were 1.2% lower at 4.87 pence on Monday.

More News
21 Jun 2018 09:17

Physiomics Expects Annual Loss To Be "Materially Reduced"

LONDON (Alliance News) - Physiomics PLC said Thursday it is trading "ahead of market expectations" for its financial year to the end of June.The company, which provides technology

Read more
23 May 2018 12:44

Physiomics Raises GBP525,000 Via Placing For Expansion (ALLISS)

LONDON (Alliance News) - Physiomics PLC on Wednesday said that it raised GBP525,000 through share placing to grow the business and expand its client base.The biotechnology company issued at

Read more
14 Mar 2018 12:42

Physiomics Awarded New GBP68,000 Innovate UK Grant For Cancer Project

LONDON (Alliance News) - Physiomics PLC said Wednesday it has been awarded a new Innovate UK Grant worth GBP68,000 for a prostate cancer -

Read more
11 Jan 2017 14:22

Physiomics makes 'good progress' towards objectives

(ShareCast News) - Physiomics announced on Wednesday that it is making good progress towards the strategic objectives announced in its most recent full year results, posted on 27 October 2016. The AIM-traded firm announced an initial payment by Sareum on 5 December, for modelling carried out by the

Read more
6 Jan 2017 12:28

Physiomics receives Innovate UK grant for cancer treatment project

(ShareCast News) - Systems biology company Physiomics confirmed on Friday that is has been awarded the Innovate UK grant as part of its Biomedical Catalyst 2016 Feasibility Study Competition that was the subject of a provisional announcement on 22 November. The AIM-traded firm said the proposed proj

Read more
22 Nov 2016 10:57

Physiomics Provisionally Awarded Innovate UK Grant

Read more
27 Oct 2016 14:15

Physiomics Annual Loss Widens After Incurring Additional Costs

Read more
21 Sep 2016 10:43

Physiomics raises £555,000 after shelving BioMoti acquisition

(ShareCast News) - AIM listed Physiomics has called off its BioMoti acquisition after investors instead backed plans to develop its modelling and simulation business with a £555,000 discounted fundraising. Physiomics, which develops software to help drug companies predict and understand cancer drug

Read more
16 May 2016 07:26

Physiomics Signs Two Extensions On Virtual Tumour Project

Read more
3 May 2016 07:39

Physiomics Appoints Andrew Clayden As Part-Time Head Of Finance

Read more
18 Apr 2016 13:41

James Millen takes the helm at Physiomics

(ShareCast News) - Physiomics had a new man at the helm on Monday, confirming Dr James Millen was taking the reins as CEO with immediate effect. The AIM-traded company said Millen, known as Jim, brought experience of drug development and licensing deals in global pharmaceutical companies with him.

Read more
18 Apr 2016 08:51

Physiomics Names James Millen As Chief Executive

Read more
4 Apr 2016 11:24

Physiomics Inks Further Contract With Speciality Pharma Customer

Read more
31 Mar 2016 10:11

Physiomics To Buy BioMoti And Raise Funds As CEO Steps Down (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.